Journal cover illustration about transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis at intermediate or low risk for surgery. Currently, the two TAVR devices approved in the US are indicated only for patients at high risk or extreme risk/inoperable, but the literature is now showing that TAVR benefits patients at intermediate or low risk for surgery, also.

Transcatheter Aortic Valve Replacement (TAVR)

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.